12 Recruiting Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
π Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Recruiting Idiopathic Pulmonary Fibrosis (IPF) Studies
π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
π UAB Hospital, School of Medicine/Lung Health Center β Birmingham, Alabama
View Study & Checklist β π΅ Active, Not Recruiting Phase1 / Phase2 π Investigational Drug / Biologic
Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis
π National Jewish Health β Denver, Colorado
View Study & Checklist β π‘ Not Yet Recruiting Interventional Protocol π Observational Clinical Research
A Comparison of a Medication Adherence Platform (FORTISKAPβ’) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension
π Pulmonary Disease Clinic, Sentara Norfolk Hospital β Norfolk, Virginia
View Study & Checklist β π’ Recruiting Phase3 π Investigational Drug / Biologic
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
π Palmtree Clinical Research Inc. β Palm Spring, California
View Study & Checklist β π’ Recruiting Interventional Protocol π Observational Clinical Research
The Genetics of Pulmonary Fibrosis
π University of Colorado Anschutz Medical Campus β Aurora, Colorado
View Study & Checklist β π’ Recruiting Phase2 π Investigational Drug / Biologic
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
π University of Alabama at Birmingham β Birmingham, Alabama
View Study & Checklist β π’ Recruiting Phase2 π Investigational Drug / Biologic
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
π Royal Prince Alfred Hospital β Camperdown, New South Wales
View Study & Checklist β π’ Recruiting Phase2 π Investigational Drug / Biologic
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
π Research Site β Birmingham, Alabama
View Study & Checklist β π’ Recruiting Phase2 π Investigational Drug / Biologic
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
π UAB Lung Health Center β Birmingham, Alabama
View Study & Checklist β